Colgate-Palmolive Company $CL has seen significant activity in recent weeks. There have been numerous buy and sell events. A few notable players include Jump Financial who sold 8,243 shares, whilst Trexquant Investment holds a solid $36.09 Million in the company. Guggenheim Capital and Kestra Advisory Services decreased their stake, whereas 1832 Asset Management and Southeast Advisors bought a large quantity of shares. Meanwhile, analysts have set a consensus price target of $98.92 for the stock. Given these mixed signals, a cautious bullish stance has been suggested. The Company is expected to continue its utilization of share buybacks and uphold the modest guidance provided suggests a thoughtful capital allocation. Despite slower growth and some headwinds, Colgate is still perceived as a top growth stock for long-term investors. Concerns over margin pressures persist, but investors are encouraged by signs of resilient growth. The most recent Q2 results were above expectations, showing a rise of 1% in net sales. This can partially be attributed to steady demand for essential products over this period.
Colgate-Palmolive Company CL News Analytics from Fri, 11 Jul 2025 07:00:00 GMT to Sat, 30 Aug 2025 16:19:47 GMT -
Rating 4
- Innovation 2
- Information 6
- Rumor -5
